Collegium Pharmaceutical (COLL) News Today $39.11 -0.41 (-1.04%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$39.12 +0.01 (+0.01%) As of 08/22/2025 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COLL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Gino Santini Sells 5,405 Shares of Collegium Pharmaceutical (NASDAQ:COLL) StockAugust 21 at 6:29 PM | marketbeat.comCollegium Pharmaceutical (COLL): Assessing Valuation Following Q2 Results and Upgraded Full-Year Revenue GuidanceAugust 21 at 10:53 AM | finance.yahoo.comCollegium Pharmaceutical (NASDAQ:COLL) EVP Scott Dreyer Sells 16,389 SharesAugust 21 at 8:00 AM | insidertrades.comFuller & Thaler Asset Management Inc. Grows Stake in Collegium Pharmaceutical, Inc. $COLLAugust 21 at 5:37 AM | marketbeat.comPublic Sector Pension Investment Board Has $3.05 Million Position in Collegium Pharmaceutical, Inc. $COLLAugust 21 at 3:52 AM | marketbeat.comGino Santini At Collegium Pharmaceutical Capitalizes: Options Exercised, Resulting In $362KAugust 20 at 8:27 PM | benzinga.comCollegium Pharmaceutical (NASDAQ:COLL) Director Sells $201,011.95 in StockAugust 20 at 5:58 AM | insidertrades.comBrandywine Global Investment Management LLC Purchases 13,792 Shares of Collegium Pharmaceutical, Inc. $COLLAugust 20 at 5:28 AM | marketbeat.comInvesco Ltd. Reduces Stake in Collegium Pharmaceutical, Inc. $COLLAugust 19, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells $184,863.83 in StockAugust 17, 2025 | marketbeat.comTejara Capital Ltd Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 17, 2025 | marketbeat.comInsider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 4,861 Shares of StockAugust 16, 2025 | insidertrades.comWe Think You Can Look Beyond Collegium Pharmaceutical's (NASDAQ:COLL) Lackluster EarningsAugust 15, 2025 | finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Makes New $3.09 Million Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 15, 2025 | marketbeat.comInsider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells 11,659 Shares of StockAugust 14, 2025 | marketbeat.comThe 5 Most Interesting Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings CallAugust 14, 2025 | finance.yahoo.com1 Stock Under $50 Worth Investigating and 2 We IgnoreAugust 14, 2025 | uk.finance.yahoo.comDirector Of Collegium Pharmaceutical Sold $400K In StockAugust 14, 2025 | benzinga.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells $400,603.24 in StockAugust 13, 2025 | insidertrades.comCollegium Pharmaceutical (NASDAQ:COLL) Upgraded by HC Wainwright to Strong-Buy RatingAugust 13, 2025 | americanbankingnews.comCOLL Q2 Deep Dive: Jornay Expansion Drives Revenue Guidance Increase, Margins Face Investment PressureAugust 12, 2025 | finance.yahoo.comCollegium Pharmaceutical Shows Market Leadership With Jump To 81 RS RatingAugust 12, 2025 | msn.comCollegium Pharmaceutical's (COLL) Buy Rating Reiterated at HC WainwrightAugust 12, 2025 | marketbeat.comIBD Rating Upgrades: Collegium Pharmaceutical Flashes Improved Relative Price StrengthAugust 11, 2025 | msn.comWall Street Zen Upgrades Collegium Pharmaceutical (NASDAQ:COLL) to "Strong-Buy"August 10, 2025 | marketbeat.comCollegium Pharmaceuticals Reports Strong Earnings and GrowthAugust 10, 2025 | theglobeandmail.comCollegium Pharmaceutical (NASDAQ:COLL) Trading 12.2% Higher - Here's What HappenedAugust 8, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | insidermonkey.comCollegium raises 2025 revenue guidance to $760M as Jornay PM growth acceleratesAugust 7, 2025 | msn.comCollegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2%August 7, 2025 | msn.comCollegium Pharmaceutical, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 7, 2025 | seekingalpha.comCollegium Reports Second Quarter 2025 Financial Results; Raises 2025 OutlookAugust 7, 2025 | globenewswire.comVestcor Inc Decreases Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 6, 2025 | marketbeat.comXTX Topco Ltd Has $636,000 Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 6, 2025 | marketbeat.comCollegium Pharmaceutical (COLL) Q2 Earnings: What To ExpectAugust 5, 2025 | finance.yahoo.com1 Cash-Producing Stock to Own for Decades and 2 We IgnoreAugust 4, 2025 | finance.yahoo.comCollegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?July 31, 2025 | finance.yahoo.comPediatrician Shares a Broad Approach to Managing ADHD in StudentsJuly 31, 2025 | yahoo.comCollegium Pharmaceutical (COLL) Projected to Post Earnings on ThursdayJuly 31, 2025 | marketbeat.com3 Reasons to Avoid COLL and 1 Stock to Buy InsteadJuly 29, 2025 | finance.yahoo.comPacer Advisors Inc. Sells 1,723,415 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)July 27, 2025 | marketbeat.comRoyce & Associates LP Has $9.03 Million Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)July 26, 2025 | marketbeat.comCollegium to Report Second Quarter 2025 Financial Results on August 7, 2025July 24, 2025 | globenewswire.comVictory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)July 24, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon CorpJuly 23, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Holdings Decreased by Segall Bryant & Hamill LLCJuly 20, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Buys 109,655 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)July 19, 2025 | marketbeat.comUnpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals StocksJuly 18, 2025 | msn.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Holdings Boosted by Emerald Advisers LLCJuly 13, 2025 | marketbeat.com8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLCJuly 12, 2025 | marketbeat.com Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address COLL Media Mentions By Week COLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COLL News Sentiment▼0.910.66▲Average Medical News Sentiment COLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COLL Articles This Week▼136▲COLL Articles Average Week Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CYTK News Today VKTX News Today TGTX News Today KRYS News Today ACAD News Today PCVX News Today AAPG News Today ACLX News Today ADMA News Today ZLAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COLL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access